Penserra Capital Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Penserra Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-119,976	Closed	-$155K	–	1258
2022 Q3	$155K	Sell	119,976 -7,222	-6%	-$15.4K	﹤0.01%	683
2022 Q2	$189K	Buy	127,198 +41,683	+49%	+$192K	0.01%	686
2022 Q1	$703K	Buy	85,515 +77,936	+1,028%	+$688K	0.02%	445
2021 Q4	$82K	Buy	+7,579	New	+$89.4K	﹤0.01%	897

Other funds holding CORZ

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

STA

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Penserra Capital Management's CORZ Position: Q4 2022 in Review

Penserra Capital Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 119,976 shares — an estimated $155K sold.

Penserra Capital Management first reported a position in CORZ in Q4 2021 and held it in 4 quarters. The position peaked at $703K in Q1 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

Penserra Capital Management reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Penserra Capital Management sold 119,976 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $155K.
Penserra Capital Management first reported a position in Core Scientific, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Penserra Capital Management's Core Scientific, Inc. Common Stock position peaked at $703K in Q1 2022.
89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Penserra Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.